QUOIN PHARMACEUTICALS, LTD.

Analyst Reco. Quoin Pharmaceuticals, Ltd.

Equities

QNRX

US74907L3006

Market Closed - Nasdaq Other stock markets 16:30:00 2024-05-01 EDT			5-day change	1st Jan Change
0.7102 ^USD	+0.32%		+12.36%	-85.52%

03-15	Maxim Group Adjusts Quoin Pharmaceuticals Price Target to $4 From $15, Maintains Buy Rating	MT
03-14	Quoin Pharmaceuticals Seeks M&A Opportunities	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Maxim Group Adjusts Quoin Pharmaceuticals Price Target to $4 From $15, Maintains Buy Rating	03-15	MT
JMP Securities Lowers Quoin Pharmaceuticals' Price Target to $6 From $15, Maintains Market Outperform Rating	23-03-10	MT
Ladenburg Thalmann Downgrades Quoin Pharmaceuticals to Neutral From Buy	23-03-10	MT
Alliance Global Partners Initiates Coverage on Quoin Pharmaceuticals With Buy Rating, $20 Price Target	22-09-07	MT
Ladenburg Lowers Quoin Pharmaceuticals' Price Target to $12 From $25, Maintains Buy Rating	22-08-23	MT
JMP Securities Lowers Quoin Pharmaceuticals' Price Target to $15 From $100, Maintains Outperform Rating	22-08-19	MT
Maxim Lowers Price Target for Quoin Pharmaceuticals to $10 From $25, Maintains Buy Rating	22-08-18	MT
Ladenburg Thalmann Starts Quoin Pharmaceuticals at Buy With $2 Price Target	22-05-06	MT
Maxim Starts Quoin Pharmaceuticals at Buy with $5 Price Target	22-01-07	MT
JMP Securities Starts Quoin Pharmaceuticals at Market Outperform With $8 Price Target	21-12-15	MT
Cellect Announces Positive Results from Cell2in Collaboration Showing Significant Improvement in Expansion Rate and Function of Stem Cells	19-03-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer